Synthesis and antiviral evaluation of novel exomethylene acyclic nucleosides and phosphonic acid nucleosides

Archiv der Pharmazie

Volumn 338, Issue 11, 2005, Pages 528-533

  Kim, Aihong ^a   Hong, Joon Hee ^a  

^a Chosun University   (South Korea)

Author keywords

Antiviral agents; Entecavir; Nucleosides; Phosphonic acid nucleoside; PMEA

Indexed keywords

1 [2 (HYDROXYMETHYL)ALLYL ESTER]CYTOSINE; 1 [2 (HYDROXYMETHYL)ALLYL ESTER]THYMINE; 1 [2 (HYDROXYMETHYL)ALLYL ESTER]URACIL; 1 [2 (HYDROXYMETHYL)ALLYLOXYMETHYLPHOSPHONIC ACID]CYTOSINE; 1 [2 (HYDROXYMETHYL)ALLYLOXYMETHYLPHOSPHONIC ACID]THYMINE; 1 [2 (HYDROXYMETHYL)ALLYLOXYMETHYLPHOSPHONIC ACID]URACIL; 9 [2 (HYDROXYMETHYL)ALLYL ESTER]ADENINE; 9 [2 (HYDROXYMETHYL)ALLYLOXYMETHYLPHOSPHONIC ACID]ADENINE; NUCLEOSIDE DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPROTECTION REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; EVALUATION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SUBSTITUTION REACTION;

ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; CYTOMEGALOVIRUS; HUMANS; METHANE; MOLECULAR STRUCTURE; NUCLEOSIDES; PHOSPHONIC ACIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 28644446348     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200500187     Document Type: Article

References (16)

1. H. J. Schaeffer, L. Beauchamp, P. de Miranda, G. B. Elion, D. J. Bauer, Nature 1978, 272, 583-585.
2. E. S. H. el Ashry, Y. El Kilany, Acylonucleosides: part 1-3 in Advances in Heterocyclic Chemisty, Academic Press 1997, Vol. 67-69.
3. E. De Clercq, J. Descamps, P. de Somer, A. Holy, Science 1978, 200, 563-566.
4. J. C. Martin, C. A. Dvorak, D. F. Smee, T. R. Mattews, J. P. Verheyden, J. Med. Chem. 1983, 26, 759-761.
5. K. O. Smith, K. S. Galloway, W. L. Kennell, K. K. Oglivie, B. K. Radatus, Antimicrob. Agents Chemother. 1982, 22, 55-61.
6. M. N. Arimilli, C. U. Kim, J. Dougherty, A. Mulato, R. Oliyai, J. P. Shaw, K. C. Cundy, N. Bischofberger, Antivir. Chem. Chemother. 1997, 8, 557-564.
7. E. De Clercq, T. Sakuma, M. Baba, R. Pauwels, J. Balzarini, I. Rosenberg, A. Holy, Antiviral Res. 1987, 8, 262-272.
8. B. L. Robbins, R. V. Srinivas, N. Bischofberger, A. Fridland, Antimicrob. Agents Chemother. 1998, 42, 612-617.
9. S. Noble, K. L. Goa, Drugs, 1999, 58, 479-487.
10. J. E. Starrett, D. R. Tortolani, J. Russell, M. J. M. Hitchcock, V. Whiterock, J. C. Martin, M. M. Mansuri, J. Med. Chem. 1994, 37, 1857-1864.
11. N. Bischofberger, R. J. Jones, Antiviral Res. 1995, 27, 1-17.
12. S. Levine, D. Hernandez, G. Yamanaka, G. S. Zhang, R. Rose, S. Weinheimer, R. J. Colonno, Antimicrob. Agents Chemother. 2002, 46, 2525-2532.
13. G. S. Jeon, V. Nair, Tetrahedron, 1996, 52, 12643-12650.
14. R. P. Panzica, R. J. Rousseau, R. K. Robins, L. B. Townsend, J. Am. Chem. Soc. 1972, 94, 4708-4714.
15. H. I. El Subbagh, S. Racha, E. Abushanab, R. P. Panzica, J. Org. Chem. 1996, 61, 890-894.
16. O. H. Ko, J. H. Hong, Arch. Pharm. Pharm. Med. Chem. 2004, 337, 579-586.